Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.94% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Inspire Medical Systems
INSP
$1.68B
| $16.1M | ﹤0.01% |
49,600
+33,369
| +206% | +$9.53M |
|
1277
Equity Residential
EQR
$24.2B
| $16.1M | ﹤0.01% |
243,514
+43,541
| +22% | +$2.72M |
|
1278
CALL
Unilever
UL
$135B
| $16M | ﹤0.01% |
+273,067
| New | +$16.2M |
|
1279
PUT
Meta Platforms (Facebook)
META
$1.52T
| $16M | ﹤0.01% |
55,700
+15,000
| +37% | +$3.7M |
|
1280
Eastman Chemical
EMN
$8.29B
| $16M | ﹤0.01% |
190,645
+24,138
| +14% | +$1.96M |
|
1281
CALL
National Grid
NGG
$81.6B
| $15.9M | ﹤0.01% |
+250,863
| New | +$16.5M |
|
1282
Avantis Emerging Markets Equity ETF
AVEM
$27B
| $15.9M | ﹤0.01% |
295,000
+75,257
| +34% | +$4M |
|
1283
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.38B
| $15.9M | ﹤0.01% |
169,289
+2,871
| +2% | +$271K |
|
1284
Norwegian Cruise Line
NCLH
$8.98B
| $15.9M | ﹤0.01% |
728,445
+69,839
| +11% | +$1.07M |
|
1285
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$449M
| $15.8M | ﹤0.01% |
201,319
-85,641
| -30% | -$6.37M |
|
1286
Royalty Pharma
RPRX
$26.4B
| $15.8M | ﹤0.01% |
513,898
+142,349
| +38% | +$4.82M |
|
1287
Royal Gold
RGLD
$19.1B
| $15.8M | ﹤0.01% |
137,270
-15,575
| -10% | -$2M |
|
|
THQ
1288
abrdn Healthcare Opportunities Fund
THQ
$810M
| $15.7M | ﹤0.01% |
825,058
+26,797
| +3% | +$505K |
|
1289
Huntington Ingalls Industries
HII
$12.9B
| $15.7M | ﹤0.01% |
69,112
+9,141
| +15% | +$1.9M |
|
1290
State Street Ultra Short Term Bond ETF
ULST
$526M
| $15.7M | ﹤0.01% |
390,851
+300,288
| +332% | +$12.1M |
|
1291
Haemonetics
HAE
$4.11B
| $15.6M | ﹤0.01% |
183,738
+2,988
| +2% | +$253K |
|
1292
Grid Dynamics Holdings
GDYN
$632M
| $15.6M | ﹤0.01% |
1,685,672
+60,708
| +4% | +$608K |
|
1293
Saia
SAIA
$10.1B
| $15.6M | ﹤0.01% |
45,531
+5,980
| +15% | +$1.73M |
|
1294
Davis Select Worldwide ETF
DWLD
$606M
| $15.6M | ﹤0.01% |
540,825
-2,485
| -0.5% | -$67.8K |
|
1295
iShares Global REIT ETF
REET
$5.08B
| $15.6M | ﹤0.01% |
677,801
+49,208
| +8% | +$1.12M |
|
1296
Repligen
RGEN
$9.45B
| $15.5M | ﹤0.01% |
109,763
+27,148
| +33% | +$4.35M |
|
1297
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $15.5M | ﹤0.01% |
238,494
+37,224
| +18% | +$2.32M |
|
1298
Dell
DELL
$320B
| $15.5M | ﹤0.01% |
286,247
-11,709
| -4% | -$539K |
|
1299
iShares MSCI China ETF
MCHI
$6.14B
| $15.5M | ﹤0.01% |
346,209
+29,304
| +9% | +$1.37M |
|
1300
ALPS Sector Dividend Dogs ETF
SDOG
$1.45B
| $15.5M | ﹤0.01% |
309,903
-63
| -0% | -$3.14K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.